Diclofenac
5 customer reviewsDiclofenac is a non-steroidal anti-inflammatory medicine for adults with pain and swelling linked to inflammatory conditions. It helps reduce inflammation so pain, stiffness, and movement can improve.
What is it?
Diclofenac is an anti-inflammatory medicine from the NSAID (non-steroidal anti-inflammatory drug) class. In day-to-day practice, it’s chosen when pain has an inflammatory component—think swollen joints, tender tendons, or a painful flare that limits movement.
One practical point patients appreciate: Diclofenac can improve function, not just pain scores, because less inflammation often means less morning stiffness and better range of motion.
Composition
Diclofenac is the active chemical compound. In medicines, it may appear as different salts that help with solubility and absorption.
Diclofenac sodium is a common oral form used to help the drug dissolve and absorb in the gastrointestinal tract. Diclofenac free acid refers to the parent molecule, which is less soluble on its own. You may also see diclofenac diethylamine mentioned for topical products, where that salt form supports delivery through the skin.
On this product page, the active ingredient is Diclofenac, supplied as tablets.
How to use?
- Take Diclofenac by mouth with water, preferably after food
- Adults are commonly prescribed a total daily dose in the 50–150 mg range, divided into 2–3 doses
- Do not exceed the prescribed daily maximum
- Use the shortest duration that controls symptoms, especially if you have ulcer or cardiovascular risk factors
Do not chew or break tablets unless your prescriber instructed it, since altering a tablet can change how quickly the dose is released and can worsen stomach irritation.
If you miss a dose, take it when you remember unless it is close to the next dose; in that case, skip the missed dose and return to your schedule. Do not double the next dose.
How does it work?
- Oral tablets: Take Diclofenac by mouth as prescribed, usually 50 mg 2 to 3 times per day. Swallow the tablet with water after meals to reduce stomach upset.
- Extended-release tablets: Take 75 mg to 100 mg once daily by mouth, preferably with food and at the same time each day.
- Do not exceed 150 mg per day unless a clinician specifically tells you to.
- Duration: Use the lowest effective dose for the shortest possible time; short-term pain relief is often a few days to 2 weeks, while longer use should be monitored by a clinician.
- Topical forms, if prescribed: Apply Diclofenac to the affected skin area 3 to 4 times daily and wash hands after use; do not apply on broken skin.
Indications
Diclofenac is used as an analgesic and anti-inflammatory for painful conditions where inflammation is part of the problem. It is also used as an antirheumatic option in inflammatory joint disease.
Typical indications include:
- Osteoarthritis pain with stiffness and swelling
- Rheumatoid arthritis symptom control (antirheumatic use)
- Acute gout flares (short-term)
- Acute back pain with inflammatory features
- Muscle and tendon pain after strain/sprain
- Post-injury or post-procedure pain where inflammation is expected
- Primary dysmenorrhea (menstrual cramps)
Comparison
Diclofenac sits within the NSAID group, alongside options like ibuprofen and naproxen, and it is often compared with COX-2–selective therapy such as celecoxib.
| Option | What it’s best for | Main cautions |
|---|---|---|
| Diclofenac | Inflammatory pain where swelling/stiffness are prominent | GI irritation, cardiovascular risk in higher-risk patients |
| Ibuprofen | Short-term mild to moderate pain, fever, flexible dosing | GI irritation; can affect kidneys with dehydration |
| Naproxen | Longer-lasting NSAID effect for some chronic pain patterns | GI irritation; longer exposure can matter in older adults |
Clinicians often view diclofenac as “strong per dose” for inflammatory pain, while naproxen may feel steadier across the day for some people due to longer duration. Celecoxib can be preferred when GI history is a dominant concern, though cardiovascular risk assessment still matters.
Contraindications
- Hypersensitivity to Diclofenac or other NSAIDs
- Active gastric ulcer or duodenal ulcer
- Severe liver dysfunction
- Severe kidney dysfunction
- Significant cardiovascular disease such as severe heart failure, coronary heart disease, or prior myocardial infarction
- Bleeding disorders or a tendency to bleed
- Bronchial asthma triggered by aspirin/NSAIDs
- Third trimester of pregnancy
- Concomitant use with other NSAIDs, including high-dose ibuprofen
- Concomitant use with anticoagulants, antiplatelets, SSRIs/SNRIs, ACE inhibitors/ARBs, diuretics, lithium, or methotrexate when clinically unsafe or requiring monitoring
Not recommended for
Risk is not the same for everyone. Age, ulcer history, cardiovascular history, asthma phenotype, kidney function, and concurrent medicines change the equation.
Not for You If
- You have hypersensitivity to Diclofenac or other NSAIDs
- You have an active gastric ulcer or duodenal ulcer
- You have severe liver dysfunction or severe kidney dysfunction
- You have significant cardiovascular disease such as severe heart failure, coronary heart disease, or a prior myocardial infarction
- You have bleeding disorders or a tendency to bleed
- You have bronchial asthma triggered by aspirin/NSAIDs
- You are in the third trimester of pregnancy
Side effects
Side effects cluster around the gut, nervous system, fluid balance, and organs that handle blood flow and drug metabolism.
Common side effects include:
- Nausea, abdominal pain, heartburn, indigestion
- Headache, dizziness, sleepiness
- Skin rash or itching
- Fluid retention, raised blood pressure in prone individuals
Serious risks (uncommon, but clinically important) include:
- Stomach or duodenal ulcer, GI bleeding (black stools, vomiting blood)
- Severe allergic reactions, including NSAID-related bronchospasm in sensitive asthma
- Kidney injury risk, higher with dehydration or existing kidney disease
- Liver enzyme elevation, and rarely clinically significant liver injury
- Cardiovascular events (heart attack, stroke) risk increases with higher doses/longer courses in at-risk patients [3]
A “real-life” warning many patients miss: ankle swelling and a sudden upward trend in home blood pressure readings can be NSAID-related, even if pain relief feels excellent.
Common mistakes
Small choices change tolerability.
- Taking Diclofenac on an empty stomach when you already have reflux or gastritis
- Combining two NSAIDs (Diclofenac plus ibuprofen or naproxen) during a bad pain day
- Using it through dehydration (sports in the heat, fasting, gastroenteritis), then blaming the drug for fatigue when the kidney stress was the real issue
- Assuming “no stomach pain” means “no GI risk”; ulcers and bleeding can be silent until they aren’t
- Ignoring blood pressure readings that rise after starting an NSAID course
Doctor opinions
In clinic, doctors often use Diclofenac as a short-course tool to “calm the flare,” then step down once mobility returns. They also tend to be stricter about NSAID duration in people with hypertension, diabetes, or a prior ulcer history, because those patients are the ones who get into trouble quietly.
Pain relief can be quick.
Side effects can also be quick.
Frequently asked questions
Many adults feel an effect within a few hours, with anti-inflammatory benefit building over a couple of days if swelling is part of the problem. Faster relief is often reported when pain is inflammatory rather than purely mechanical. Timing still varies with food intake and individual absorption. This aligns with pharmacology described in EMA product information for diclofenac-containing medicines (2024).
Diclofenac can cause dizziness or drowsiness in some people, especially early in treatment or when combined with other sedating medicines. If you operate machinery or drive for work, pay attention to the first doses before assuming you’ll be unaffected. Headache and light-headedness are also reported and can mimic dehydration. MOHAP patient medicine-use guidance (2025) flags impairment risk with medicines that cause drowsiness.
NSAIDs can raise blood pressure and cause fluid retention in susceptible individuals, so a stable hypertension plan can become unstable during a course. This is more likely with longer use, higher doses, and in people taking ACE inhibitors/ARBs plus a diuretic. If your home readings rise during treatment, the safer move is to reassess the NSAID course rather than pushing through. EMA NSAID risk communication (2024) includes blood pressure and cardiovascular risk considerations.
People with a history of ulcer, GI bleeding, or ongoing reflux often need a protective plan if an NSAID is necessary. Doctors may use a proton pump inhibitor (PPI) strategy in higher-risk patients, while aiming for the lowest effective NSAID dose and shortest course. New abdominal pain, black stools, or vomiting that looks like coffee grounds are red flags. WHO pharmacovigilance materials (2023) list GI bleeding symptoms that warrant urgent assessment.
Kidneys rely on prostaglandins to maintain blood flow during stress states like dehydration. By reducing prostaglandins, Diclofenac can tip vulnerable patients into kidney injury, even over a short period. Risk rises with dehydration, older age, chronic kidney disease, and combinations with diuretics and ACE inhibitors/ARBs. EMA product information (2024) discusses renal adverse effects as a known NSAID class issue.
Front view
Side view
Back view
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.
Diclofenac — Comparison with alternatives
Diclofenac Current
Zomig Best rated
Sibelium
Depo-Medrol Best price
Decadron
Reviews and Experiences
Sources
- European Medicines Agency (EMA) (2013). Summary of Product Characteristics (SmPC) — Diclofenac (systemic use). ↑
- Ministry of Health and Prevention (MOHAP) (2025). Guidance on safe use of medicines and reporting adverse drug reactions in the UAE. ↑
- European Medicines Agency (EMA) (2013). PRAC assessment: cardiovascular and gastrointestinal risks of systemic diclofenac-containing medicines. ↑
- World Health Organization (WHO) (2023). WHO Pharmacovigilance: Safety of non-steroidal anti-inflammatory drugs (NSAIDs). ↑
- European Medicines Agency (EMA) (2024). Public health communication on NSAID risk minimisation and patient selection. ↑